Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

NCT03029234 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed and Refractory Multiple Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Carfilzomib

Sponsor

Amgen

Collaborators

[object Object]